Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion

NCT01958164 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Catheter Obstruction
Vascular Access Devices

Interventions

DRUG: Actilyse
DRUG: Saline solution
DRUG: Actilyse
DRUG: Actilyse

Sponsor

Boehringer Ingelheim